Anavex announces first entire clinical alzheimer's gene pathway data of anavex®2-73 at aaic 2022

Expression levels of pathological dysregulated neurodegenerative genes of both alzheimer's and parkinson's disease were significantly restored by the therapeutic effect of anavex®2-73 (p

AVXL Ratings Summary

AVXL Quant Ranking